User menu

Antisense Inhibition of P210 Bcr-abl in Chronic Myeloid-leukemia

Bibliographic reference Vaerman, JL. ; Lewalle, P. ; Martiat, P.. Antisense Inhibition of P210 Bcr-abl in Chronic Myeloid-leukemia.PORTOFINO SYMP ON AUTOGRAFTING FOR CHRONIC MYELOID LEUKEMIA : STATUS OF THE ART (PORTOFINO(Italy), Aug 19-20, 1993). In: Stem Cells : the international journal of cell differentiation and proliferation, Vol. 11, p. 89-95 (1993)
Permanent URL http://hdl.handle.net/2078.1/63380
  1. Nowell, Science, 132, 1497 (1960)
  2. Rowley, Nature, 243, 290 (1973)
  3. de Klein, Nature, 300, 765 (1982)
  4. Shtivelman, Nature, 315, 550 (1985)
  5. Konopka, Cell, 37, 1035 (1984)
  6. Martiat, Blood, 78, 205 (1991)
  7. Daley, Science, 247, 824 (1990)
  8. Elefanty, EMBO J, 9, 1069 (1990)
  9. Heisterkamp, Nature, 344, 251 (1990)
  10. Anfossi, Proc Natl Acad Sci USA, 86, 3379 (1989)
  11. Ratajczak, Blood, 79, 1956 (1992)
  12. Goldman, Leukemia, 3, 163 (1990)
  13. Taj, Leukemia and Lymphoma, 3, 201 (1990)
  14. Szczylik, Science, 253, 562 (1991)
  15. Calabretta B. In vitro and in vivo suppression of Philadelphia‐positive leukemia cells growth by bcr‐abl antisense oligodeoxynucleotides. 2nd Int Conference on Chronic Myeloid Leukemia, Bologna 1992. Abstract 61.
  16. Mahon, Lancet, 341, 566 (1993)
  17. Snyder, Blood, 78, 330a (1991)
  18. Martiat, Blood, 81, 502 (1993)
  19. Ratajczak, Proc Natl Acad Sci USA, 89, 11823 (1993)
  20. Woolf, Proc Natl Acad Sci USA, 89, 7305 (1992)
  21. Akhtar, Life Sciences, 49, 1793 (1991)
  22. Grosveld G, Verwoerd T, van Agthoven T, de Klein A, Ramachandran K L, Heisterkamp N, Stam K, Groffen J, The chronic myelocytic cell line K562 contains a breakpoint in bcr and produces a chimeric bcr/c-abl transcript., 10.1128/mcb.6.2.607
  23. Daley, Proc Natl Acad Sci USA, 85, 9312 (1988)
  24. Merrouche, Hum Gene Ther, 3, 285 (1992)